Novasep names CEO chair of board
This article was originally published in Scrip
Pompey, France-based Novasep, a global molecule and fine chemical manufacturer for life sciences, has named current chief executive officer Michel Spagnol chair of its supervisory board. Michel Spagnol joined Novasep as its CEO in June 2013. He replaces company founder Roger-Marc Nicoud as chair of the board.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.